Japan Considers Increasing Production Of Avian Flu Vaccine
This article was originally published in PharmAsia News
Japan's Ministry of Health, Labor and Welfare is considering increasing production of avian flu vaccine, adding to the current stockpile of 10 million doses. In preparing for the possibility of an avian flu epidemic, with vaccine production taking six months, the government plans to produce the pandemic vaccine based on the highly mutable H5N1 type virus, to be used by medical workers immediately following an epidemic outbreak. A more effective vaccine can be produced later on for the general population. (Click here for more-Japanese language
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.